Cargando…
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that block immune inhibitory pathways. Administration of ICIs augments T cell-mediated immune responses against tumor, resulting in improved overall survival in cancer patients. It has emerged that the intestinal microbiome can modulate r...
Autores principales: | Hayase, Eiko, Jenq, Robert R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220726/ https://www.ncbi.nlm.nih.gov/pubmed/34162429 http://dx.doi.org/10.1186/s13073-021-00923-w |
Ejemplares similares
-
Microbiome influencers of checkpoint blockade–associated toxicity
por: Wang, Yinghong, et al.
Publicado: (2023) -
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite
por: Renga, Giorgia, et al.
Publicado: (2022) -
New insights about immune populations in gastrointestinal GvHD
por: Hayase, Eiko, et al.
Publicado: (2023) -
Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013) -
Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
por: Wang, Dongdong, et al.
Publicado: (2023)